[1]Gosselin,Francis;O'Shea,PaulD.;Webster,RobertA.;Reamer,RobertA.;Tillyer,RichardD.;Grabowski,EdwardJ.J.[Synlett,2006,#19,p.3267-3270]
[2]Börgel,Jonas;Tanwar,Lalita;Berger,Florian;Ritter,Tobias[JournaloftheAmericanChemicalSociety,2018,vol.140,#47,p.16026-16031]
[3]Sthalam,VinayKumar;Singh,AjayK.;Pabbaraja,Srihari[OrganicProcessResearchandDevelopment,2019,vol.23,#9,p.1892-1899]
[4]Yamakawa,Naoki;Suzuki,Koichiro;Yamashita,Yasunobu;Katsu,Takashi;Hanaya,Kengo;Shoji,Mitsuru;Sugai,Takeshi;Mizushima,Tohru[BioorganicandMedicinalChemistry,2014,vol.22,#8,p.2529-2534]
[5]Penning,ThomasD.;Talley,JohnJ.;Bertenshaw,StephenR.;Carter,JefferyS.;Collins,PaulW.;Docter,Stephen;Graneto,MatthewJ.;Lee,LenF.;Malecha,JamesW.;Miyashiro,JulieM.;Rogers,RolandS.;Rogier;Yu,StellaS.;Anderson,GaryD.;Burton,EarlG.;Cogburn,J.Nita;Gregory,SusanA.;Koboldt,CarolM.;Perkins,WilliamE.;Seibert,Karen;Veenhuizen,AmyW.;Zhang,YanY.;Isakson,PeterC.[JournalofMedicinalChemistry,1997,vol.40,#9,p.1347-1365]
[1]CurrentPatentAssignee:ZOETISINC.-US5466823,1995,A
[1]CurrentPatentAssignee:ZOETISINC.-US5521207,1996,A
[1]Gosselin,Francis;O'Shea,PaulD.;Webster,RobertA.;Reamer,RobertA.;Tillyer,RichardD.;Grabowski,EdwardJ.J.[Synlett,2006,#19,p.3267-3270]
Title: 4-(5-Phenyl-3-trifluoro-meth-yl-1H-pyrazol-1--yl)benzene-sulfonamide.
Journal: Acta crystallographica. Section E, Structure reports online 20110901
Title: Biomarkers of inflammation in cattle determining the effectiveness of anti-inflammatory drugs.
Journal: Journal of veterinary pharmacology and therapeutics 20100201
Title: Estimation of binding affinities for celecoxib analogues with COX-2 via Monte Carlo-extended linear response.
Journal: Bioorganic & medicinal chemistry letters 20020211
Title: Three-dimensional quantitative structure-activity relationships of cyclo-oxygenase-2 (COX-2) inhibitors: a comparative molecular field analysis.
Journal: Journal of medicinal chemistry 20010927
Title: Vinay Kumar Sthalam, et al. An Integrated Continuous Flow Micro-Total Ultrafast Process System (μ-TUFPS) for the Synthesis of Celecoxib and Other Cyclooxygenase Inhibitors. RETURN TO ISSUEPREVARTICLENEXT
